In a SWOG Cancer Research Network trial that put three targeted drugs to the test, the small molecule inhibitor cabozantinib was found most effective in treating patients with metastatic papillary kidney cancer.
In this episode of In the Headlines, Paul Goldberg, publisher of The Cancer Letter, and Jacquelyn Cobb, associate editor, talk about controversial data cited in Trump’s “Make American Healthy Again” executive order that claims that the U.S. has the highest age-standardized incidence rate of cancer globally. But where did that data come from?
